Sebti, M.; Schweitzer-Chaput, A.; Cisternino, S.; Hinterlang, M.; Ancedy, D.; Lam, S.; Auvity, S.; Cotteret, C.; Lortholary, O.; Schlatter, J.
Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? Pharmaceuticals 2024, 17, 691.
https://doi.org/10.3390/ph17060691
AMA Style
Sebti M, Schweitzer-Chaput A, Cisternino S, Hinterlang M, Ancedy D, Lam S, Auvity S, Cotteret C, Lortholary O, Schlatter J.
Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? Pharmaceuticals. 2024; 17(6):691.
https://doi.org/10.3390/ph17060691
Chicago/Turabian Style
Sebti, Maria, Arnaud Schweitzer-Chaput, Salvatore Cisternino, Mélanie Hinterlang, Dimitri Ancedy, Sandrine Lam, Sylvain Auvity, Camille Cotteret, Olivier Lortholary, and Joël Schlatter.
2024. "Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?" Pharmaceuticals 17, no. 6: 691.
https://doi.org/10.3390/ph17060691
APA Style
Sebti, M., Schweitzer-Chaput, A., Cisternino, S., Hinterlang, M., Ancedy, D., Lam, S., Auvity, S., Cotteret, C., Lortholary, O., & Schlatter, J.
(2024). Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? Pharmaceuticals, 17(6), 691.
https://doi.org/10.3390/ph17060691
